Search Results

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal: implications for targeted therapies by Schneider, Meike (Author) , Korzeniewski, Nina (Author) , Merkle, Konstanze (Author) , Schuler, Julia (Author) , Grüllich, Carsten (Author) , Hadaschik, Boris (Author) , Hohenfellner, Markus (Author) , Duensing, Stefan (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3β and PTP1B in situ by Petri, Meike Katinka (Author) , Koch, P. (Author) , Stenzinger, Albrecht (Author) , Kuchelmeister, K. (Author) , Nestler, U. (Author) , Paradowska, A. (Author) , Steger, K. (Author) , Brobeil, A. (Author) , Viard, M. (Author) , Wimmer, M. (Author) ,


    Get full text
    Article (Journal) Online Resource